// App-Quantinova.ai

3123 : Aberrant expression of CD33 is associated with poor prognosis in patients with multiple myeloma and tumor progression

Researchers

Presenter

  • Ki Hong Lee

Principal Investigators

  • Hee Seoung Seo

  • Ji Yeon Sohn

  • Eunyoung Lee

  • Hyewon Lee

  • Hyeon-Seok Eom

  • Sun-Young Kong

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

  • Solid malignancies

Biomarkers

  • B-lymphocyte antigen CD20

  • Cluster of Differentiation 19

  • Cluster of Differentiation 38

  • Cluster of differentiation 45

  • Cluster of Differentiation 56

  • KIT Proto-Oncogene, Receptor Tyrosine Kinase

  • Syndecan-1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved